Bioventus (BVS) Common Equity (2020 - 2026)
Bioventus (BVS) recorded Common Equity of $277.41 million in Q2 2026, up 37.8% from $201.3 million a year earlier and up 18.4% from the prior quarter.
Bioventus (BVS) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Bioventus reported Common Equity of $228.45 million, up 23.1% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $185.6 million in FY2024 (-16.1%), $221.12 million in FY2023 (-46.4%), $412.22 million in FY2022 (-32.2%) and $607.66 million in FY2021 (+321.5%).
- The Q2 2026 figure is the highest quarterly Common Equity since Q4 2022.
- On a year-over-year basis, Common Equity has increased for five consecutive quarters, with growth averaging 7.0% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 321.5% in Q4 2021, against a decline of 60.6% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $234.27 million (Q1 2026), $228.45 million (Q4 2025) and $207.26 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Bioventus | 1.18 Bn | 1.07 Bn | 105.67 Mn | 277.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 277.41 Mn |
| Mar 28, 2026 | 234.27 Mn |
| Dec 31, 2025 | 228.45 Mn |
| Sep 27, 2025 | 207.26 Mn |
| Jun 28, 2025 | 201.30 Mn |
| Mar 29, 2025 | 185.48 Mn |
| Dec 31, 2024 | 185.60 Mn |
| Sep 28, 2024 | 186.83 Mn |
| Jun 29, 2024 | 189.06 Mn |
| Mar 30, 2024 | 217.43 Mn |
| Dec 31, 2023 | 221.12 Mn |
| Sep 30, 2023 | 226.46 Mn |
| Jul 1, 2023 | 233.34 Mn |
| Apr 1, 2023 | 240.36 Mn |
| Dec 31, 2022 | 412.22 Mn |
| Oct 1, 2022 | 451.04 Mn |
| Jul 2, 2022 | 592.08 Mn |
| Apr 2, 2022 | 593.81 Mn |
| Dec 31, 2021 | 607.66 Mn |
| Oct 2, 2021 | 230.50 Mn |
Bioventus Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();